Abstract
There has been a recent boom of monoclonal antibodies on the market, and a significant portion of them were produced by NS0 cell lines. As regulations become more stringent in ensuring production processes are free of potential contamination by adventitious agents, it is highly desirable to further develop serum-free media into ones that do not contain any components of animal origin, or ‘animal-free media’. Using a shake-flask batch culture system, recombinant proteins (human albumin and human insulin) and synthetic compounds (tropolone and ferric ammonium citrate) were identified to be capable of replacing the animal-sourced proteins commonly found in serum-free media for NS0 cell culture, namely bovine albumin, insulin and transferrin. The cholesterol requirement of NS0 cells was satisfied by the use of a commercially available non-proteinaceous, non-animal sourced cholesterol/fatty acid mix in place of bovine lipoproteins, which in effect also eliminated the need for recombinant albumin. In the animal-free medium thus formulated, NS0 cell lines, either the host or recombinant constructs, were all able to grow in batch culture to 1~ 3×106 viable cells/ml for multiple passages, with no requirement for gradual adaptation even when seeded from 10% serum-containing cultures. It was surprising to observe that the recombinant insulin was essentially ineffective as sodium salt compared to its zinc salt. Studies showed that the zinc deficiency in the former resulted in a rapid decline of cell viabilities. Supplementation of zinc ions greatly improved growth, and even led to the total replacement of recombinant insulin and hence the formulation of a protein-free medium. When the cell lines were adapted to cholesterol-independent growth which eliminated the need for any lipid source, a completely chemically-defined animal-free medium was formulated. In all cases, antibody production by various GS-NS0 constructs in animal-free media was stable for multiple passages and at least similar to the original serum-free medium containing the animal-sourced proteins. The medium also served well for cryopreservation of NS0 cells in the absence of serum.
Similar content being viewed by others
References
D.W. Allison K.A. Aboytes D.K. Fong S.L. Leugers T.K. Johnson H.N. Loke L.M. Donahue (2004) ArticleTitleDevelopment and optimization of cell culture media BioProc. Int.. 2 38–45
L.M. Barnes C.M. Bentley A.J. Dickson (2000) ArticleTitleAdvances in animal cell recombinant protein production: GS-NS0 expression system Cytotechnology 32 109–123 Occurrence Handle1:CAS:528:DC%2BD3cXis1yjuro%3D
C.R. Bebbington G. Renner S. Thompson D. King D. Abrams G.T. Yarranton (1992) ArticleTitleHigh level expression of a recombinant antibody from myeloma cells using a glutamine-synthetase gene as an amplifiable selectable marker Biotechnology 10 169–175 Occurrence Handle1:CAS:528:DyaK38XksVKisro%3D Occurrence Handle1369477
J.R. Birch R.C. Boraston H. Metcalfe M.E. Brown C.R. Bebbington R.P. Field (1994) ArticleTitleSelecting and designing cell lines for improved physiological characteristics Cytotechnology 15 11–16 Occurrence Handle10.1007/BF00762375 Occurrence Handle1:STN:280:ByqB3c%2Fnt1M%3D Occurrence Handle7765922
J.R. Birch S.J. Froud (1994) ArticleTitleMammalian cell culture systems for recombinant protein production Biologicals 22 127–133 Occurrence Handle10.1006/biol.1994.1019 Occurrence Handle1:CAS:528:DyaK2cXlslOkt7c%3D Occurrence Handle7917229
M.F. Brown G. Renner R.P. Field T. Hassell (1992) ArticleTitleProcess development for the production of recombinant antibodies using glutamine synthetase (GS system) Cytotechnology 9 231–236 Occurrence Handle1:STN:280:ByyC2Mboslc%3D Occurrence Handle1369497
Buser C.W., Beaudet R., Soohoo N. and Pugh G.G. 1994. Development of serum-free media for engineered NS0 cell lines. In: Spier R.E, Griffiths J.B. and Berthold W.(eds.), Animal Cell Technology: Products of Today, Prospects of Tomorrow. Butterworth-Heinemann, pp. 121–139.
P.M.L. Castro P.M. Hayter A.P. Ison A.T. Bull (1992) ArticleTitleApplication of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells Appl. Microbiol. Biotechnol. 38 84–90 Occurrence Handle10.1007/BF00169424 Occurrence Handle1:CAS:528:DyaK3sXitlagt7w%3D Occurrence Handle1369013
T.G. Cotter M. Al-Rubeai (1995) ArticleTitleCell death (apoptosis) in cell culture systems and possible prevention using an anti-apoptotic gene or compound Trends Biotechnol. 13 150–155 Occurrence Handle10.1016/S0167-7799(00)88926-X Occurrence Handle1:CAS:528:DyaK2MXltFejur8%3D Occurrence Handle7766111
R.J. Cousins R.K. Banchard M.P. Popp L. Liu J. Cao J.B. Moore C.L. Green (2003) ArticleTitleA global view of the selectivity of zinc deprivation and excess on genes expressed inhuman THP-1 mononuclear cells PNAS 100 6952–6957 Occurrence Handle10.1073/pnas.0732111100 Occurrence Handle1:CAS:528:DC%2BD3sXkslOntL4%3D Occurrence Handle12756304
R.C. Das K.J. Morrow SuffixJr. (2004) Antibody Therapeutics: Product DevelopmentMarket Trends and Strategic Issues D&MD Publications WestboroughMA
J. Dempsey S. Ruddock M. Osborne A. Ridley S. Stuart R. Field (2003) ArticleTitleImproved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase Biotechnol. Prog. 19 175–178 Occurrence Handle10.1021/bp0256061 Occurrence Handle1:CAS:528:DC%2BD38XpsVSnsrg%3D Occurrence Handle12573022
EMEA 2002. Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathies via human and veterinary medicinal products. EMEA/410/01 Rev.
FDA 2004. Tysabri (natalizumab). U.S. Food and Drug Administration web-site November 26, (2004) updated.
R.P. Field (2003) Animal cell culture Lonza Group AG, Assignee
D.N. Galbraith (2002) ArticleTitleTransmissible spongiform encephalopathies and tissue cell culture Cytotechnology 39 117–124 Occurrence Handle10.1023/A:1022935117274
Galfre G. and Milstein C. 1981. Preparation of monoclonal antibodies: strategies and procedure. In: Langone J.J. and Vunakis H.V.(eds.), Methods Enzym. Academic Press, 73: 3–46.
A. Gambhir C. Zhang A. Europa W.S. Hu (1999) ArticleTitleAnalysis of the use of fortified medium in continuous culture of mammalian cells Cytotechnology 31 243–254 Occurrence Handle10.1023/A:1008026613975 Occurrence Handle1:CAS:528:DyaK1MXnvVaqu70%3D
S. Gorfien B. Paul J. Walowitz R. Keem W. Biddle D. Jayme (2000) ArticleTitleGrowth of NS0 cells in protein-freechemically-defined medium Biotechnol. Prog. 16 682–687 Occurrence Handle10.1021/bp000109a Occurrence Handle1:CAS:528:DC%2BD3cXmsFeisbY%3D Occurrence Handle11027156
Gorfien S.F., Fike R.M., Dzimian J.L., Godwin J.P., Price P.J., Epstein D.A., Gruber D. and McClure C. 1998. Suspension culture of mammalian cells in medium containing poly-cationic or -anionic compound. Patent application WO9808934.
K.B. Hellman J.P. Honstead C.K. Vincent (1996) ArticleTitleAdventitious agents from animal-derived raw materials and production systems Develop. Biol. Standard. 88 231–234 Occurrence Handle1:STN:280:ByiC28bnvVQ%3D
R. Ilouz O. Kaidanovich D. Gurwitz H. Eldar-Finkelman (2002) ArticleTitleInhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc Biochem. Biophy. Res. Comm. 295 102–106 Occurrence Handle1:CAS:528:DC%2BD38Xksl2ms7g%3D
O. Izaki (1989) ArticleTitleIIb group metal ions (Zn2+Cd2+Hg2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes J. Biol. Chem. 264 16118–16222
D.W. Jayme (1991) ArticleTitleNutrient optimization for high density biological production applications Cytotechnology 5 15–30 Occurrence Handle10.1007/BF00365531 Occurrence Handle1:STN:280:By6B3MvnvVY%3D Occurrence Handle1367048
D.W. Jayme (1999) ArticleTitleAn animal origin perspective of common constituents of serum-free medium formulations Develop. Biol. Standard. 99 181–187 Occurrence Handle1:STN:280:DyaK1MzjtFOktw%3D%3D
K.J. Keen C. Hale (1996) ArticleTitleThe use of serum-free medium for the production of functionally active humanized monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker Cytotechnology 18 207–217 Occurrence Handle10.1007/BF00767768
M.J. Keen T.W. Steward (1995) ArticleTitleAdaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium Cytotechnology 17 203–211 Occurrence Handle1:CAS:528:DyaK2sXltl2isr4%3D
G. Kohler C. Milstein (1976) ArticleTitleDerivation of specific antibody-producing tissue culture and tumor lines by cell fusion Eur. J. Immunol. 6 511–519 Occurrence Handle1:STN:280:CSiD2cflvVE%3D Occurrence Handle825377
J. Kovar C. Franek (1987) ArticleTitleIron compounds at high concentrations enable mouse hybridoma and myeloma cells to grow in protein-free medium Eur. Congr. Biotechnol. 3 614–617
Mainwaring D.O., Maxwell A., Rendall M.H., Blewett J.M., Racher A.J. and Wayte J.R.T. 2002. Development of improved chemically-defined mammalian cell culture fermentation processes. Poster presentation at 224th ACS National Meeting, Boston, MA.
Metcalfe H., Field R.P. and Froud S.J. 1994. The use of 2-hydroxy-2,4,6-cycloheptarin-1-one (tropolone) as a replacement for transferrin. In: Spier R.EGriffiths J.B. and Berthold W.(eds.),Animal Cell Technology: Products of Today, Prospects of Tomorrow. Butterworth-Heinemann, pp. 88–90.
O.W. Merten (1999) ArticleTitleSafety issues of animal products used in serum-free media Develop. Biol. Standard. 99 167–180 Occurrence Handle1:STN:280:DyaK1MzjtFOktg%3D%3D
O.W. Merten (2002) ArticleTitleVirus contaminations of cell cultures – a biotechnological view Cytotechnology 39 91–116
O.W. Merten S. Petres E. Couve (1995) ArticleTitleA simple serum-free freezing medium for serum-free cultured cells Biologicals 23 185–189 Occurrence Handle10.1006/biol.1995.0030 Occurrence Handle1:STN:280:BymD3M3ltFA%3D Occurrence Handle7546662
W.M. Mullett E.P.C. Lai J.M. Yeung (2000) ArticleTitleSurface plasmon resonance-based immunoassays Methods 22 77–91 Occurrence Handle10.1006/meth.2000.1039 Occurrence Handle1:CAS:528:DC%2BD3cXnslWmtb0%3D Occurrence Handle11020321
Robinson D.K., Distefano D.J., Gould S.L., Cuca G., Seamans T.C., Benincasa D., Munshi S., Chan C.P., Lee D.K., Stanfor-Hollis J., Hollis G.F., Jain D., Ramasubramanyan K., Mark G.E. and Silberklang M. 1995. Production of engineered antibodies in myeloma and hybridoma cells – enhancements in gene expression and process design. In: Antibody Engineering. ACS Symposium Series 604 pp.1–14.
R.G. Robwer (1996) ArticleTitleAnalysis of risk to biomedical products developed from animal sources (with special emphasis on the transmissible spongiform encephalopathies, TSEs) Develop. Biol. Standard. 88 247–256
J.D. Sato T. Kawamoto T. Okamoto (1987) ArticleTitleCholesterol requirement of P3-X63-Ag8 mouse myeloma cells for gowth in vitro J. Exp. Med. 165 1761–1766 Occurrence Handle10.1084/jem.165.6.1761 Occurrence Handle1:CAS:528:DyaL2sXltFertrg%3D Occurrence Handle3585251
J.D. Sato H.T. Cao Y. Kayada M.C. Cabot G.H. Sato T. Okamoto C.J. Welsh (1988) ArticleTitleEffect of proximate cholesterol precursors and steroid hormones on mouse myeloma growth in serum-free medium In Vitro 24 1223–1228 Occurrence Handle1:CAS:528:DyaL1MXhtlaqsb8%3D
Schmelzer A.E., Weymer C.L. and Varma A. 2004. Optimized fed-batch bioreactors for NS0 antibody production. Presentation at 227th ACS National Meeting, AnaheimCA.
Talley D., Cutak B., Rathbone E., Al-Kolla T., Allison D., Blasberg J., Kao K. and Caple M. 2003. SyntheChoTM synthetic cholesterol for cholesterol dependent cell culture – development of non-animal derived chemically defined NS0 medium. Sigma Technical Bulletin.
Tsao Y.S., Gould S.L. and Robinson D.K. 2000. Cell culture media. In: Miller W. et al. (eds), Encyclopedia of Animal and Plant Cell Technology. J. Wiley & Sons, pp.35–31.
Varma A., Schmelzer A.E., White S., Patel M., DiGirolamo C. and Case S. 2003. Enhanced antibody production yields from NS0 cells. Presentation at the 8th Watersides Conference, SanFrancisco, CA.
W. Whitford B. Barnett B. Pence (2004) HyQ®CDM4NS0TM: the next generation CD NS0 culture medium Poster presentation at IBC/BioProcess International Conference & Exhibition Boston, MA
V.T. Wong K.W. Ho G.S. Yap (2004a) ArticleTitleEvaluation of insulin-mimetic trace metals as insulin replacements in mammalian cell cultures Cytotechnology 45 107–115 Occurrence Handle10.1007/s10616-004-6173-2 Occurrence Handle1:CAS:528:DC%2BD2MXivFelsbk%3D
Wong V., Nissom P.M., Sim S.L., Yeo J. and Yap M. 2004b. Correlating the productivity and transcriptional profile of hybridoma cells. Presentation at 227th ACS National Meeting, Anaheim CA.
L. Xie D.I.C. Wang (1994) ArticleTitleApplication of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor Cytotechnology 15 17–29 Occurrence Handle10.1007/BF00762376 Occurrence Handle1:STN:280:ByqB3c%2FntlE%3D Occurrence Handle7765929
L. Xie D.I.C. Wang (1997) ArticleTitleIntegrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells Trends Biotechnol. 15 109–113 Occurrence Handle10.1016/S0167-7799(97)01014-7 Occurrence Handle1:CAS:528:DyaK2sXhvFSksLc%3D Occurrence Handle9080717
W. Zhou C.C. Chen B. Buckland J. Aunins (1997) ArticleTitleFed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production Biotechnol. Bioeng. 55 783–792 Occurrence Handle10.1002/(SICI)1097-0290(19970905)55:5<783::AID-BIT8>3.0.CO;2-7 Occurrence Handle1:CAS:528:DyaK2sXkslyhurw%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, J., Robinson, D. Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture. Cytotechnology 48, 59–74 (2005). https://doi.org/10.1007/s10616-005-3563-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10616-005-3563-z